Clinsys Clinical Research

Mr. Mosur is the CEO and President of Jubilant Drug Discovery and Development, a division of Jubilant Organosys Ltd. JDDS, comprised of Jubilant Chemsys, Jubilant Biosys and Clinsys Clinical Research, Inc., is a pharmaceutical services provider focused on drug discovery and development, manufacturing, and healthcare solutions. A chemical engineer by training, Mr. Mosur develops and directs R&D and healthcare alliances between mature and emerging markets. With more than 19 years of pharmaceutical development experience, Mr. Mosur has worked with many of the major global pharmaceutical, biotech and venture funding companies developing successful alliances for early drug discovery through manufacturing.

Mr. Dasgupta has more than 25 years of experience in the drug discovery and development industry. Before joining Clinsys, he was a founder and director of Lambda Therapeutic Research Ltd. Prior to Lambda, Mr. Dasgupta was with Ranbaxy Laboratories Ltd., where he focused on bioequivalence studies and project management of outsourced projects to CROs based in North America. He is a founding member of the Association of Contract Research Organizations (ACRO) in India and a recipient of the Udyog Ratna Award for contributions toward industrial development in India. Mr. Dasgupta earned his master's degree in pharmacy from the University of Delhi.

Mr. Devnani was previously controller for corporate accounts at Jubilant, and his background includes accounts and information systems management for other Indian firms. Mr. Devnani ensures that accounting and reporting regulations are met, as well as integrating cutting-edge information systems technologies to ensure maximum effectiveness. Mr. Devnani graduated from the Sri Ram College of Commerce at the University of Delhi in India and holds further qualification certificates from the Institute of Cost and Work Accountants of India and the Institute of Company Secretaries of India.

Ms. Lewis is responsible for overseeing all activities for North America and European Operations. She determines the strategic direction and growth of these regions while delivering quality service and results to Clinsys clients worldwide. To fulfill her duties, Ms. Lewis capitalizes on her more than 20 years of clinical research experience in multiple therapeutic areas including infectious diseases, gastroenterology, cardiovascular, CNS, ophthalmology, dermatology and women's health. Ms. Lewis also has extensive experience with global development programs and has developed strategies for NDA approvals, post-marketing studies and supplemental indications. Prior to joining Clinsys, Ms. Lewis held positions of increasing responsibility at PharmaNet, SFBC International and Otsuka America Pharmaceutical Inc. A graduate of the University of North Carolina at Chapel Hill with a bachelor's in chemistry, Ms. Lewis holds a masters of science in biotechnology from Johns Hopkins University.

Dr. Schmied, a highly experienced professional in the field of cardiovascular clinical research, previously worked as executive director of European operations for Medifacts International, as well as global head of clinical research. Prior to Medifacts, he held a number of senior management positions in clinical development for Bayer AG. Dr. Schmied received his doctorate of medicine from the University of Cologne, Germany and a certificate in pharmaceutical medicine from the European Confederation of the Upper Rhine Universities in Basel, Strasbourg and Freiburg.

Ms. Flynn is responsible for leading Clinsys' Quality Assurance and Compliance Department, while also serving as Clinsys' key contact person for the FDA and other regulatory authorities. She has more than 25 years of experience in the pharmaceutical industry, with 14 years in international quality assurance and regulatory compliance. Ms. Flynn has held esteemed positions at Clingenix, Covance, Clinical Studies, Boehringer Mannheim and Sandoz. She earned her bachelor's degree in biology/chemistry at West Chester University in West Chester, PA and is certified by the American Society of Clinical Pathologists as a histology technician.

Ms. Bland has more than 13 years of experience in the pharmaceutical contract research industry. She is responsible for the development of proposals and contracts on a global basis. Ms. Bland began as a proposal and contracts analyst, progressing into the role of Director of Proposals for the Oncology Therapeutics Division of Quintiles, Inc. Most recently, she held key roles as Director and then Vice President of the Proposals and Contracts Departments at INC Research, Inc. Ms. Bland earned a bachelor's degree in communications from North Carolina State University.

Ms. Grant has more than 25 years of experience in human resources and recruiting concentrated in the pharmaceutical/CRO industries. Prior to joining Clinsys she was Human Capital Partner and Recruitment Manager at i3 Global. Her past human resource experience includes positions at Johnson & Johnson, Ortho-McNeil Pharmaceutical and Nelson Professional Sales where she held the position of Vice President Human Resources and Recruiting. Ms. Grant earned a bachelor's degree from Montclair University.